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SUMMARY
Peptidoglycan surrounds the bacterial cytoplasmic
membrane to protect the cell against osmolysis.
The biosynthesis of peptidoglycan, made of glycan
strands crosslinked by short peptides, is the target
of antibiotics like b-lactams and glycopeptides.
Nascent peptidoglycan contains pentapeptides that
are trimmed by carboxypeptidases to tetra- and
tripeptides. The well-characterized DD-carboxypep-
tidases hydrolyze the terminal D-alanine from the
stem pentapeptide to produce a tetrapeptide. How-
ever, few LD-carboxypeptidases that produce tri-
peptides have been identified, and nothing is known
about substrate specificity in these enzymes. We
report biochemical properties and crystal structures
of the LD-carboxypeptidases LdcB from Strepto-
coccus pneumoniae, Bacillus anthracis, and Bacillus
subtilis. The enzymes are active against bacterial cell
wall tetrapeptides and adopt a zinc-carboxypepti-
dase fold characteristic of the LAS superfamily. We
have also solved the structure of S. pneumoniae
LdcB with a product mimic, elucidating the residues
essential for peptidoglycan recognition and the
conformational changes that occur on ligandbinding.
INTRODUCTION
Bacteria surround their cytoplasmic membrane with a large,
semipermeable barrier, the peptidoglycan (PG) sacculus, which
not only protects the cell from lysis from turgor but also helps
to maintain cell shape. PG comprises repeating units of the
N-acetylglucosamine-N-acetylmuramicacid (GlcNAc—MurNAc)
disaccharide that polymerizes into longglycanchains.Pentapep-
tides, usually comprising L-Ala—D-g-Glu[Gln]—L-Lys—D-Ala—
D-Ala, extend from theMurNAcmoiety. In Gram-negative bacte-
ria and some Gram-positive Firmicutes, the L-Lys at position 3
is replaced by meso-diaminopimelic acid (A2pm), which is
amidated in Bacillus subtilis (Vollmer et al., 2008a). Peptides pro-
truding fromadjacent glycan chains are crosslinked by transpep-
tidases to form the net-like PG sacculus, which the cell has to
enlarge in order to grow and to divide (Sauvage et al., 2008).
Newly inserted PGmatures and is turned over by PG hydrolases,
and the balance between synthesis and degradation of PG is key
to normal cell division (Vollmer et al., 2008b). The importance of
PG to the healthy physiology of a bacterium is highlighted by
the fact that its biosynthesis is the target of someof ourmost suc-
cessful antibiotics, b-lactams such as penicillin and glycopep-
tides such as vancomycin, resistance to which in pathogens is
an urgent and currently unmet human health challenge.
In most species, the terminal D-alanine of the nascent penta-
peptide stem is hydrolysed by DD-carboxypeptidases from the
class C penicillin binding protein (PBP) family (Lovering et al.,
2012). LD-carboxypeptidases subsequently hydrolyze the
L-Lys[A2pm]—D-Ala bond to release the tripeptide. Though tri-
peptides are found inmany bacteria, very few of the correspond-
ing LD-carboxypeptidases have been identified. Membrane
preparations of B. subtilis have shown strong LD-carboxypepti-
dase activity against cell-wall-derived tetrapeptides (Arminjon
et al., 1977), though the specific enzyme involved has not been
isolated. The best characterized LD-carboxypeptidase is LD-
carboxypeptidase A (LdcA), a cytoplasmic, penicillin-insensitive
member of the S66 family of serine peptidases that is involved in
PG recycling and is essential for cells entering the stationary
phase (Metz et al., 1986; Templin et al., 1999). The cytoplasmic
localization of LdcA precludes its involvement in the production
of cell wall tripeptides. Other LD-carboxypeptidases either must
be active within the periplasm of Gram-negative bacteria or are
anchored to the exterior of the cell membrane in Gram-positives.
Several LD-carboxypeptidase genes have been identified
recently, including dacB from Lactococcus lactis and Strepto-
coccus pneumoniae (Barendt et al., 2011; Courtin et al., 2006),
csd6 from Helicobacter pylori (Sycuro et al., 2012) and pgp2
Structure 22, 949–960, July 8, 2014 ª2014 The Authors 949
fromCampylobacter jejuni (Frirdich et al., 2014), though it should
be noted that csd6 and pgp2 share no sequence similarity with
dacB. The corresponding null mutants exhibited increased
amounts of tetrapeptides in the cell wall and a concomitant
decrease in tripeptide content (Sycuro et al., 2012; Frirdich
et al., 2014). The S. pneumoniae dacB mutant also displayed
severe morphological defects, developing into small, spherical
cells or elongating into long, thick cells, as a result of division
asymmetry produced by random septum localization (Barendt
et al., 2011). Both the H. pylori csd6 and the C. jejuni pgp2
mutants have a morphological defect, displaying a straight
shape instead of the normal helical morphology, indicating that
csd6 and pgp2 also contribute to cell shape maintenance (Frir-
dich et al., 2014; Sycuro et al., 2012). In C. jejuni (Frirdich et al.,
2012) and H. pylori (Sycuro et al., 2010), cell shape is also linked
to pathogenicity, and PG fragments released by growing cells
are important signaling molecules for immune recognition and
modulation in animals ranging from insects to man (Royet
et al., 2011). Therefore, the PG plays an important role in bac-
terial shape maintenance, viability, virulence and immune
signaling.
In this study, we have investigated the biochemical activity of
S. pneumoniae and B. subtilis DacB against cell wall sacculi and
synthetic tetrapeptides. Both proteins are shown to be active
against cell-wall-derived tetrapeptides and synthetic tetra-
peptides lacking the sugar moiety but are inactive against tetra-
peptides terminating in L-alanine, confirming their classification
as LD-carboxypeptidases. We therefore propose to rename
these enzymes LD-carboxypeptidase B (LdcB). We present the
crystal structures of both LdcB enzymes and the ortholog from
Bacillus anthracis, all of which belong to the LAS (lysostaphin,
D-Ala-D-Ala metallopeptidases, sonic hedgehog) family of
zinc-dependent peptidases. The structure of S. pneumoniae
LdcB with MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn) bound
reveals the molecular basis of PG recognition and the key roles
played in catalysis by active site elements. It is surprising that
the active site is reminiscent, yet reversed, of that found in
pancreatic carboxypeptidase A, suggesting that the enzymes
have converged on a common catalytic mechanism.
RESULTS
Role for LdcB In Vivo
The mature PG of S. pneumoniae and B. subtilis contains mostly
tripeptides, indicating the presence of PG-active peptidases in
these organisms (Atrih et al., 1999; Bui et al., 2012). Both species
contain DacA orthologs, DD-carboxypeptidases that cleave
pentapeptides to tetrapeptides; however, the LD-carboxypepti-
dases that produce tripeptides from the tetrapeptides have
remained elusive until recently. The PG of a S. pneumoniae
dacB mutant contained mainly tetrapeptides, suggesting
strongly that SpDacB is an LD-carboxypeptidase (hereinafter
renamed as SpLdcB) (Barendt et al., 2011). Single mutants of
the dacA and dacB orthologs inB. subtilis, dacA, and yodJ (here-
inafter renamed as ldcB), had no obvious phenotype during
vegetative growth, indicating that the trimming of peptides or
the released D-Ala is not required for growth under laboratory
conditions (Atrih et al., 1999). To test whether the released
D-Ala becomes important under D-Ala limiting conditions, we
constructed dacA and ldcB null mutants in a B. subtilis strain
auxotrophic for D-Ala (an alanine racemase [alrA] null mutant)
and assayed growth in the presence of D-Ala. The D-Ala-depen-
dent strain, RD180, required at least 450 mM D-Ala for normal
growth, and it grew more slowly at lower D-Ala concentrations
(Figure 1). However, strains also bearing either the dacA (KS03)
or the ldcB (KS02) alleles exhibited even more severe growth
rate dependencies on D-Ala, with the dacA mutant the most
severely affected. These data suggest strongly that LdcB is an
LD-carboxypeptidase that releases D-Ala from the cell wall,
which can be used to support growth under D-Ala-limiting
conditions.
To test directly whether LdcB functions as an LD-carboxypep-
tidase, we generatedS. pneumoniae andB. subtilis ldcBmutants
and isolated their cell wall PG. Muropeptides were released with
cellosyl and analyzed by HPLC (Figures 2A and 2B). The ldcB
mutant strains lacked tripeptides and containedmainly tetrapep-
tides in their PGs, consistent with previous work indicating that
LdcB is the main enzyme trimming cell wall tetrapeptides
(Barendt et al., 2011). To obtain more direct evidence for an
enzymatic activity, purified, recombinant LdcB enzymes from
S. pneumoniae and B. subtilis (termed SpLdcB and BsLdcB)
were incubatedwith PG isolated from the respective ldcBmutant
strains before digesting with cellosyl and analyzing the resulting
muropeptides by HPLC (Figures 2A and 2B). Both SpLdcB and
BsLdcB almost quantitatively digested PG tetrapeptides with a
Figure 1. Effect of dacA and ldcB Alleles in a D-alanine Auxotroph
(A–C) The growth of strains (A) RD180 (DalrA), (B) KS02 (DldcBDalrA), and (C)
KS03 (DdacADalrA) incubated at 37!C in LB medium supplemented with
different concentrations of D-alanine was determined by monitoring the cul-
ture at OD600 and plotting it against time of incubation.
(D) The calculated growth rate of each strain at three different concentrations
of exogenous D-alanine. The values shown represent the average of three
independent experiments. The dashed line shows the growth rate of wild-type
B. subtilis strain 168CA under the same conditions. The error bars represent
the SD of growth rate means at a confidence level of 95%.
Structure
Structure of the LdcB LD-Carboxypeptidase
950 Structure 22, 949–960, July 8, 2014 ª2014 The Authors
carboxy-terminal D-Ala producing the tripeptides, proving their
LD-carboxypeptidase activity. SpLdcB was active in the pres-
ence of Zn2+ ions and inactive in the presence of EDTA, suggest-
ing a metal-ion-dependent peptidase mechanism.
SpLdcB and BsLdcB Are Catalytically Active against
Synthetic Cell Wall Tetrapeptides
In addition to removing the terminal D-Ala from S. pneumoniae
cell wall PG tetrapeptides (Figure 2A), SpLdcB was also tested
against synthetic tetrapeptides (L-Ala—D-Gln—L-Lys—D-Ala
[tetra-D]) and its L-isomer, L-Ala—D-Gln—L-Lys—L-Ala [tetra-
L]). Though these substrates lack the glycan component and
differ further from the natural substrate by the replacement of
D-g-glutamine with D-glutamine, they have the potential to
discriminate between LD- and LL-carboxypeptidase activities.
SpLdcB was active solely against the tetra-D ligand (Figure 2C),
an activity that was dependent on the presence of zinc and abro-
gated totally in the presence of EDTA (Figure 2C).
Overall Structure of LdcB
The crystal structures of SpLdcB and Bacillus anthracis LdcB
(BaLdcB) were solved by single wavelength anomalous disper-
sion (SAD); BsLdcB was solved by molecular replacement. The
LdcB enzymes are single domain proteins comprising two sub-
domains separated by a V-shaped cleft (Figures 3A–3C). The first
subdomain comprises a four-stranded, antiparallel b sheet (b4–
b7) that opposes the cleft, and the outside face of the b sheet
is flanked by three a helices (a1, a4, and a6). The second subdo-
main comprises an N-terminal, three-stranded, antiparallel b
sheet (b1–b3), somewhat discrete from the four helical bundle
(a2, a3, a5, and a7) that makes up the rest of the subdomain.
Though the BaLdcB structure contains the same subdomain, it
is less well structured in this region than BsLdcB and SpLdcB,
and, as a consequence, the b1–b3 sheet is not formed. Neither
subdomain is formed by a contiguous, linear part of the primary
sequence; six loops (b3–a1, b4–a2, a3–b5, b6–a5, a5–b7, and
a6–a7) connect the two subdomains.
The cleft between subdomains is 15–18 A˚ wide at the top
and 15 A˚ deep and narrows down to the base where a Zn2+
ion, added to the enzyme during purification, is located (Fig-
ures 3A–3C), which is coordinated in a tetrahedral manner
by three amino acids. In SpLdcB, the liganding residues are
His153, Asp160, and His207 (Figure 3D); the equivalents in
BsLdcB/BaLdcB are His185/His160, Asp192/Asp167, and
His244/His219 (Figures 3E and 3F). These zinc ligands are uni-
versally conserved in LdcB sequences, consistent with an
important functional role in these enzymes. The active site of
SpLdcB contains unattributed residual electron density that
occupies the position of the fourth ligand in the tetrahedral
coordination sphere of the zinc (Figure 3D). To use the nomen-
clature common to proteases, the unattributed electron den-
sity extends as far as the S1
0 subsite, the location ordinarily
occupied by the scissile amino acid. The electron density in
the S1
0 subsite is of a size, shape, and location corresponding
to that of alanine. The ligand is stabilized in this position
by van der Waals’ contacts between the alanyl methyl group
Figure 2. Activity of SpLdcB and BsLdcB
against Peptidoglycan and Peptides
(A) HPLC chromatograms of muropeptides from
S. pneumoniae strains, obtained after incubating
PG with or without SpLdcB or SpLdcB(E204A)
in the presence of Zn2+ or EDTA, followed by
digestion with cellosyl and reduction with
sodium borohydride. The muropeptides are: Tri,
GlcNAc—MurNAc(r)—L-Ala—D-g-Gln—L-Lys;
Tetra, GlcNAc—MurNAc(r)—L-Ala—D-g-Gln—L-
Lys-D-Ala; TetraTri, GlcNAc—MurNAc—L-Ala—
D-g-Gln—L-Lys—D-Ala—L-Lys—D-g-Gln—L-
Ala—MurNAc(r)—GlcNAc; TetraTetra, GlcNAc—
MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Ala)—
D-Ala—L-Lys—D-g-Gln—L-Ala—MurNAc(r)—Glc
NAc; deAc, deacetylation at GlcNAc; SA, L-Ser—
L-Ala branch (at L-Lys). GlcNAc, N-acetylglusos-
amine; MurNAc(r), N-acetylmuramitol.
(B) HPLC chromatograms of muropeptides from
B. subtilis strains, obtained after incubating PG
with or without BsLdcB, followed by digestion
with cellosyl and reduction with sodium borohy-
dride. Muropeptides: Tri, GlcNAc—MurNAc(r)—L-
Ala—D-g-Glu—meso-Dap(NH2); Tetra, GlcNAc—
MurNAc(r)—L-Ala—D-g-Glu—meso-Dap(NH2)—
D-Ala; TetraTri, GlcNAc—MurNAc—L-Ala—D-g-
Glu—meso-Dap(NH2)—D-Ala-meso-Dap(NH2)— D-
g-Glu—L-Ala—MurNAc(r)—GlcNAc; TetraTetra,
GlcNAc—MurNAc—L-Ala—D-g-Glu—meso-Dap
(NH2)—(D-Ala)—D-Ala—meso-Dap(NH2)— D-g-
Glu—L-Ala—MurNAc(r)—GlcNAc;meso-Dap(NH2),
meso-diaminopimelic acid (amidated).
(C) TLC of SpLdcB incubated with various sub-
strates.
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and the phenolic side chains of Tyr191 and Tyr201 and by
hydrogen bonds to the side chains of Glu204 and the main
chain amide nitrogen of Tyr144. Despite the high resolution
of the SpLdcB diffraction data, it was not possible to discrim-
inate between either alanyl stereoisomer, both of which are
present in the crystallization conditions. We have modeled
D-Ala because it is the enzymatic product of these enzymes.
However, residual electron density adjacent to the zinc ion
could not be modeled satisfactorily with any ligand arising
from the enzymatic activity, the crystallization media, or purifi-
cation media; consequently, the remaining electron density
has been left unmodeled. Mass differences between native
and denatured protein samples also failed to identify candi-
date molecules corresponding to the residual electron density.
Residual electron density in the vicinity of the fourth zinc ligand
in BsLdcB was fulfilled by a phosphate anion, a component of
the crystallization conditions (Figure 3E), which refined satis-
factorily. The phosphate is located so as to mimic the tetrahe-
dral transition state of amide bond hydrolysis. There is a
further unmodeled electron density feature (Figure 3E), this
time in the S1
0 subsite, that we have not been able to identify
unambiguously.
Comparison of LdcB Structures
SpLdcB, BaLdcB, and BsLdcB share pairwise sequence identi-
ties of #30%, and they superimpose on #155 common Ca
atoms with a root-mean-square deviation (rmsd) of 1.5 A˚–
1.8 A˚ (Figures 3A–3C). The major differences between the
LdcB structures are limited to the rather flexible and uncon-
strained N- and C-termini and the occasional longer loop in
one structure in comparison to the other, as a direct conse-
quence of sequence insertions. The active sites of SpLdcB,
BaLdcB, and BsLdcB are, to all extents and purposes, indistin-
guishable (Figures 3D–3F). A further BaLdcB structure has been
solved that contains no bound zinc ion, but there are negligible
differences between it and its counterpart with zinc bound (Fig-
ure S1 available online). The active site of the LdcB enzymes is,
therefore, sculpted in a robust fashion, competent for peptidol-
ysis once the catalytic machinery is completed by the incorpo-
ration of zinc.
Structural Comparison with Other Peptidases
Using SpLdcB as a search model in DALI (Holm and Rose-
nstro¨m, 2010), over 100 significantly similar structures were
identified in the Protein Data Bank (PDB), including the struc-
ture of VanXYG, a dipeptidase/DD-carboxypeptidase (PDB ID
4f78 [Meziane-Cherif et al., 2014]; DALI Z score = 17.0); an
endolysin from the Listeria bacteriophage A500 (PDB ID 2vo9
[Korndo¨rfer et al., 2008]; Z = 9.5); VanX, a DD-dipeptidase
(PDB ID 1r44 [Bussiere et al., 1998]; Z = 6.6); and the N-termi-
nal domain of sonic hedgehog, a protease involved in embryo-
genesis (PDB ID 2wg4 [Bishop et al., 2009]; Z = 5.3). Equivalent
results were obtained using the structures of BaLdcB and
BsLdcB as queries in DALI. The matched structures are all
members of the wider LAS superfamily of proteases (Bochtler
et al., 2004), which, although they share very little sequence
identity, possess markedly similar active sites (Figure 4). By
comparison with the VanXYG structure (Meziane-Cherif et al.,
2014), the active site of the LdcB proteins is open and more
solvent accessible. The open nature of the active site is a direct
consequence of the absence of the b4-a5/bisubstrate selec-
tivity loop in LdcB, which enables the recognition of PG, a
molecule far greater in size than the dipeptides utilized by Van-
XYG (Meziane-Cherif et al., 2014).
Figure 3. Structure of LdcB
(A–C) Cartoon representations of (A) SpLdcB, (B) BsLdcB, and (C) BaLdcB; a helices (red) and b strands (yellow) are numbered. The loops between secondary
structure elements are colored silver. The bound zinc ion is shown as a gray sphere.
(D–F) The active sites of (D) SpLdcB, (E) BsLdcB, and (F) BaLdcB. A zinc ion is coordinated in a tetrahedral manner in the structures by two invariant histidines
and a well-conserved aspartate. Residual electron density in SpLdcB, shown in (D), corresponds to D-alanine in the S1
0 subsite, and an unknown compound in
S1, adjacent to the zinc ion. Electron density corresponding to a phosphate ion, a component of the crystallization medium, in the S1 subsite of BsLdcB shown
in (E) is a mimic of the tetrahedral transition state. A second feature in the S1
0 subsite is unmodeled. The residual difference density features are shown
contoured at a level of 3s and hydrogen bonds are drawn as dashed black lines.
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As with other LAS superfamily members, LdcB contains the
characteristic zinc binding motif (Figure 4), with a consensus
sequence of H-X(3–6)-D-X(not conserved)-H. The fourth zinc ligand
in the structures of other LAS family members tends to be a
solute from the crystallization milieu or a water that is likely to
act as the nucleophile in the reaction (Bussiere et al., 1998). A
second conserved motif in the LAS superfamily, H-X-H, of which
the first histidine is the catalytic residue (Bochtler et al., 2004), is
missing from LdcB enzymes; the catalytic histidine is replaced
spatially by glutamate (i.e., Glu204 in SpLdcB).
SpLdcB Cocrystallized with a Reaction Product
Despite attempting to crystallise LdcB enzymes with a range of
synthetic ligands, one crystal structure was obtained, that of
SpLdcB in complex with MurNAc—L-Ala—D-g-Gln—L-Lys—
(D-Asn) (Figure 5A). This ligand is a close chemical analog of
the true reaction product, as it contains half of the repeating
unit of the glycan component of PG and comprises a tripeptide
stem peptide that is branched at the L-lysine, the location of
the crosslink position in natural PG (Figures 5F and 5G). There
are two chemical differences between this synthetic mimic and
the true reaction product. First, the ligand lacks GlcNAc, the sec-
ond sugar moiety of the glycan repeating unit in PG. Second, the
terminal D-Asn group is covalently attached by a peptide bond
between the main chain carbonyl of the terminal D-Asn and the
side chain Nz of the penultimate lysine. In crosslinks between
peptide stems, the side chain Nz of the penultimate lysine is
linked by a peptide bond to the main chain carbonyl of a
D-Ala. Hence, the L-Lys—(D-Asn) linkage is a faithful mimic of
the natural L-Lys—(D-Ala), albeit the chemistry of the side chains
of the terminal D-amino acids clearly differ.
There are six molecules of SpLdcB in this crystallographic
asymmetric unit, though none of the interfaces represent a stable
multimeric form. Five of six protein chains could be built and
refined satisfactorily; the electron density for the sixth copy could
not be improved by any procedure to permit its reliable
modeling, and its absence from the model contributes directly
to the slightly inflated final Rwork and Rfree values (Table 1). The
five built molecules are highly superimposable, with each other
and with the apo SpLdcB structure (rmsds between 0.5 A˚ and
1.1 A˚; Table 2). In chains B, C, and E, the zinc is coordinated
by a likely nucleophilic water to form tetrahedral coordination
geometry. In chain D, the fourth zinc ligand is not evident,
perhaps due to local disorder. Residual electron density was
retained throughout refinement in only one of the five molecules,
chain A, into which MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn)
could be built and refined unambiguously (Figure 5A).
The structure of the ligand-bound form of SpLdcB is entirely
consistent with its LD-carboxypeptidase function. First, the
MurNAc moiety is situated at the very top of the intersubdomain
cavity and makes little contact with the protein. This part of the
ligand has the highest B factors (a mean of 93 A˚3, versus a
mean of 83 A˚3 for the intact ligand and a mean of 45 A˚3 for all
atoms modeled) and, thus, the weakest electron density. The
MurNAcO1 andO4 atoms, which define the location of the flank-
ing b1- to b4-linked GlcNAc sugars in PG, project away from the
protein surface so that the glycan chain would be accommo-
dated by the protein without steric clashes. The N-acetyl group
at C1 is stabilized against the side chain of Met202 by van der
Waals’ forces (Figure 5B).
The Ca and Cb atoms of L-alanine at position 1 of the peptide
pack against the face of Tyr144, a conserved amino acid in many
LdcB sequences, to discriminate against the D-stereoisomer in
this subsite, S3. L-alanine is favored by contacts with Tyr144
andMet202, which discriminate against all L-amino acids bulkier
than alanine (Figure 5B). The NH2 group of the D-g-Gln of
position 2 is located in subsite S2, 2.3 A˚ away from and in
hydrogen bonding distance of Glu204 (Figure 5C), an invariant
amino acid in LdcB sequences. Stereoselectivity at this position
is maintained because L-g-glutamine would clash with Tyr144.
The g-glutamine is selected for by specific interactions with the
main chain carbonyl of Ala203 and the side chain of Glu204 while
ensuring that the scissile peptide bond is in the catalytic position.
These key aspects of molecular recognition could not occur with
commonly occurring amino acids. Canonical glutamine can be
accommodated at this position in the synthetic peptide, tetra-D,
because the absence of contacts with one face of the peptide
provides scope for the conformational changes needed to
accommodate glutamine in the absence of the glycan strands
of the natural substrate.
Position 3 of the peptide is occupied by L-lysine. D-lysine
could not be accommodated at this position because of the
presence nearby of Glu107. As expected of a reaction product
complex, the lysine carboxylate is located adjacent to the active
site zinc in subsite S1 (Figure 5D). One of the carboxylic oxygens
completes the zinc tetrahedral geometry with His153/Asp160/
His207, and the second oxygen forms a salt bridge with
Figure 4. A Comparison of the Active Sites of LdcB and Other LAS
Family Members
LdcB shares an active site closely superimposable on those of other LAS
family enzymes. The zinc is coordinated by a H-X(3–6)-D-X(not conserved)-H motif.
A glutamate that plays a key role in catalysis is also shown; note that, in D-Ala-
D-Ala carboxypeptidase from Streptomyces albus, the equivalent amino acid
is histidine, the first amino acid in the H-X-H motif common to most LAS
carboxypeptidases. The structures shown, distinguished by the coloring of
carbon atoms, are SpLdcB (white), BsLdcB (green), BaLdcB (orange),
Enterococcus faecalis D,D-dipeptidase/D,D-carboxypeptidase VanXYG (yel-
low; PDB ID 4f78), Enterococcus faecium aminodipeptidase VanX (blue; PDB
ID 1r44) and S. albus D-Ala-D-Ala carboxypeptidase (pink; PDB ID 1lbu).
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Arg120, which is either arginine or lysine in LdcB orthologs. The
L-lysine carboxylate thus represents a posthydrolysis state,
placed appropriately for the peptide bond of the substrate to
be hydrolyzed by the water molecule that fulfils the fourth zinc
ligand in the absence of substrate.
The side chain of the L-lysine twists back against the rest of
the peptide and projects into the protein core to place the termi-
nal D-Asn branch in subsite S1
0, against the main chain atoms of
Tyr144 and the side chains of Tyr191, Tyr201, and His207 (Fig-
ure 5E). The carbonyl of the L-Lys—(D-Asn) peptide bond is con-
tacted by the side chain of Ser151. However, it should be noted
that subsite S1
0 would be occupied by the scissile D-alanine in
the presence of the reaction substrate, and support for this
hypothesis comes from the structure of VanXYG solved in com-
plex with a phosphinate transition state mimic (Figure 6A) (PDB
ID 4muq) (Meziane-Cherif et al., 2014). The phosphinate moiety
is a transition state mimic of peptide bond hydrolysis because
the reaction proceeds via a tetrahedral intermediate that phos-
phinate mimics. VanXYG superimposes on SpLdcB with an
rmsd of 1.6 A˚ on 144 matched Cas, and the alanyl carboxylate
moiety of the phosphinate is situated in an analogous position
to that of the L-Lys—(D-Asn) peptide linkage observed in
SpLdcB (Figure 6A). The phosphate atoms of the phosphinate
transition state mimic superimpose almost identically with the
phosphate anion modeled adjacent to the zinc ion in the struc-
ture of BsLdcB (Figure 3D). Other than Ser151, a role in deter-
mining specificity for the terminal D-alanine can be invoked
for Gln125, and both these amino acids are strictly conserved.
The amide nitrogen of Ala146 also participates in stereoselec-
tivity, but as this is a main chain atom, it is perhaps no surprise
that sequence conservation is not maintained at this position.
However, crosslinks between peptide stems cannot be
accommodated in the observed conformation because of the
burial of the branched amino acid in subsite S1
0 (Figure 6B).
Mere rotation of the side chain torsion angles of the L-lysine
would result in a more thermodynamically favored extended
conformation for this side chain to result in it passing beyond
Arg120, Leu128, and Tyr132 to project beyond the surface of
the protein (Figure 6B; Figure S2). In this conformation, cross-
linked peptide stems attached to the terminal Nz would not be
sterically occluded by the body of the protein, consistent with
the observed cleavage of crosslinked peptides (Figure 2A). In
Figure 5. SpLdcB with Bound MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn)
(A) Cartoon representation of SpLdcB, drawn using the same color scheme as in Figure 3. The MurNAc—Ala—D-g-Gln—L-Lys—(D-Asn) is drawn as a ball-and-
stick model with Refmac-weighted 2Fobs-Fcalc electron density displayed at a contour level of 1 s.
(B–E) The interactions made between the ligand and the protein at each subsite are shown successive panels: (B) S3; (C) S2; (D) S1, and (E) S1
0. Key van derWaals’
interactions are shown as a transparent silver line.
(F) A schematic of the interactions of SpLdcB with the bound peptidoglycan mimic. Hydrogen-bond interactions are shown with a black dotted line, and van der
Waals’ forces are shown with a green arc.
(G) A schematic of the tetrapeptide substrate of SpLdcB, drawn in the same manner as the peptidoglycan mimic in (F). The scissile bond is highlighted by an
arrow. Crosslinks to other stem peptides would take place via the lysine’s terminal amino group on the left.
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some bacteria, the lysine is replaced with diaminopimelic acid, a
carboxy derivative of lysine that is amidated in bacilli. While the
amidocarboxy derivative could be stabilized in the observed
conformation by a similar set of specific interactions, it would
also sterically occlude crosslinked peptide stems. Diaminopi-
melic acid is thus likely to follow the same path predicted for
lysine by forming a simple, extended conformation to project
into solvent.
Several key structural changes occur on ligand binding in
SpLdcB (Figure 7; Movie S1). First and foremost, substrates are
occluded in the empty formof the enzyme by a loop between res-
idues Gly163 and Glu171, which blocks access to the active site.
Most of these residues (Asp167 toGlu171)moveby10–15 A˚ in the
presence of ligand to open up the cleft by refolding into an addi-
tional turn at the N terminus of a-helix 4. The rearrangement of
these residues is accompanied by further conformational
changes in Trp206, the indole ring of which moves by up to 9 A˚,
which not only aids to open up the active site of the enzyme but
also forces the side chain of Glu204 to rearrange to take up a po-
sition capable of interactingwith the substrate. The importance of
Glu204and the zinc ion for catalysis is highlightedby theobserva-
tion that tetra-D is a much poorer substrate for the E204A variant
of SpLdcB (Figure 2A) and by the absence of activity in the pres-
ence of EDTA (Figures 2A and 2C). The conformational changes
seen on ligand binding to SpLdcB contrasts with the absence
of significant conformational changes described for VanXYG in
complex with phosphinate (PDB ID 4muq) (Meziane-Cherif
et al., 2014). Like LdcB, VanXYG maintains the H-X(3–6)-D-
X(not conserved)-Hmotif, and as also observed in LdcB, the catalytic
H-X-H motif is replaced by a glutamate. The resculpting of the N
terminus ofa-helix 4 inSpLdcB to accommodate the tetrapeptide
is not necessary in VanXYG, because this enzyme hydrolyzes a
much smaller substrate, D-Ala-D-Ala dipeptide, which is accom-
modated by the enzyme without significant rearrangement.
Table 1. Summary of X-Ray Data Collection and Refinement Statistics
Parameters SpLdcB BsLdcB SpLdcB with Ligand BaLdcB BaLdcB with Zinc
PDB ID 4OX5 4OX3 4OXD 4JID 4MPH
Data collection
Space group I222 P212121 C2 I222 I222
Unit Cell Dimensions
a, b, c (A˚) 48.8, 60.4, 138.2 42.7, 53.7, 102.4 346.0, 42.5, 79.3 76.6, 113.0, 124.6 76.8, 112.3, 125.7
a, b, g (!) 90, 90, 90 90, 90, 90 90, 93.1, 90 90, 90, 90 90, 90, 90
Wavelength (A˚) 0.98 0.97 0.92 0.97856 1.27696
Resolution (A˚) 20.0–1.80 (1.84–1.80) 47.6–1.70 (1.73–1.70) 47.8–2.80 (2.95–2.80) 29.7–2.30 (2.36–2.30) 28.3–2.03 (2.06–2.03)
Multiplicity 24.3 (14.2) 3.2 (1.7) 3.4 (3.4) 4.2 (3.6) 11.8 (9.9)
Rmerge
a 0.077 (0.108) 0.072 (0.235) 0.134 (0.635) 0.093 (0.542) 0.101 (0.511)
I/sI 34.4 (2.4) 11.9 (2.4) 7.8 (1.9) 13.5 (2.4) 32.1 (4.2)
Completeness (%) 98.6 (86.9) 95.7 (89.3) 98.3 (98.3) 98.3 (94.3) 99.8 (96.9)
Refinement
Resolution (A˚) 20.0–1.80 47.6–2.0 47.8–2.80 29.7–2.3 28.3–2.03
No. of reflections 25,656 (1,157) 35,526 (1,057) 47,327 (1,979) 22,730 (1,226) 67,494 (3,374)
Rwork/Rfree
b 0.191/0.253 0.176/0.247 0.273/0.335 0.194/0.259 0.151/0.189
No. of Atoms
Protein 1,476 1,753 7,014 3,040 2,970
No. of proteins/AU 1 1 6 2 2
Ion/ligand 3/22 1/5 21/51 -/4 2/12
Water 197 230 111 424 466
B Factors (A˚2)
Protein 41.8 16.0 44.3 45.3 35.8
Ion/ligand 36.9/50.7 10.7/23.8 38.7/69.7 $/49.8 17.9/60.0
Water 48.2 31.6 28.7 43.6 46.2
Rmsd
Bond lengths (A˚) 0.018 0.015 0.005 0.013 0.0012
Bond angles (!) 1.96 1.76 0.84 1.36 0.991
Ramachandran
Favored (%) 96.1 96.7 95.8 97.6 98.0
Allowed (%) 100 100 99.6 99.7 100
Highest resolution shell shown in parentheses. AU, asymmetric units.
aRmerge = ShSijIi(h) $ hI(h)i/ShSiIi(h), where Ii(h) and hI(h)i are the ith and mean measurement of the intensity of reflection h.
bRwork/Rfree = SjFp
obs $ Fp
calcj/SFp
obs, where Fp
obs and Fp
calc are the observed and calculated structure factor amplitudes, respectively.
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DISCUSSION
The presence of tripeptides in the bacterial cell wall implies that
LD-carboxypeptidase activity must be present in the extracel-
lular milieu. In this study, we have shown that LdcB, from both
S. pneumoniae and B subtilis, are active against tetrapeptides
found within the bacterial cell wall and are specific for LD link-
ages, confirming the LD-carboxypeptidase classification with a
role in cell wall maturation. The precise in vivo role for LdcB re-
mains to be determined; one possibility is that the enzyme
allows recycling of D-Ala from the cell wall to support further
cell wall synthesis and, thus, growth. Alternatively, the cleavage
of D-Ala from the cell wall might permit the differentiation
between old and new cell walls, a potentially powerful way to
ensure the correct localization of new cell wall synthesis. The
correct localization of new PG synthesis is likely to be more
important to bacteria that have polarized cell growth, such as
Streptococci, in comparison to those that have dispersed
growth along the length of a cylinder (e.g., Bacilli) or that utilize
a division-only mechanism, such as Staphylococci. The cell
morphological defect observed in the S. pneumoniae ldcB
mutant, and the absence of defect in the B. subtilis ldcBmutant,
could be consistent with this premise. Further studies should
distinguish these possibilities.
We also present crystal structures of BaLdcB, BsLdcB, and
SpLdcB, the latter also in complex with a PG-fragment analog
that has enabled the identification of amino acids key to molec-
ular recognition of the substrate and a potential tunnel through
which crosslinked PG peptides may pass during proteolysis.
LdcB belongs to the LAS group of zincmetalloproteases; several
members of this family are active against PG, albeit with different
substrate specificities to LdcB, including the Gly-Gly endopepti-
dase lysostaphin (Korndo¨rfer et al., 2008) and the DD-/LD-endo-
peptidase MepA (Marcyjaniak et al., 2004). LdcB is dissimilar
to other groups of LD-carboxypeptidases, e.g., Pseudomonas
aeruginosa LD-carboxypeptidase LdcA (PDB ID 1ZRS) (Korza
and Bochtler, 2005) that degrades cell wall tetrapeptides in the
cytoplasm. LdcA utilizes a Ser-His-Glu catalytic triad in catalysis
and belongs to the S66 serine protease family of enzymes, a
group with which LdcB shares no similarity (Korza and Bochtler,
2005). Likewise, LdcB shares no sequence similarity with Csd6
and Pgp2, two recently discovered LD-carboxypeptidases that
aid to maintain the helical shape of H. pylori (Sycuro et al.,
2012) and C. jejuni (Frirdich et al., 2014). Csd6 and Pgp2 belong
to an LD-transpeptidase family that utilizes a conserved Cys/His
motif for catalysis (Biarrotte-Sorin et al., 2006), and are,
Table 2. Rmsd Values between Ligand-Bound SpLdcB Chains
(4OXD) and apo SpLdcB (4OX5)
4OX5 and
4OXD Chain 4OX5
4OXD
Chain A
4OXD
Chain B
4OXD
Chain C
4OXD
Chain D
4OXD
Chain E
4OX5 – 0.73 0.57 0.66 0.69 0.80
4OXD chain A 0.73 – 0.63 0.64 0.76 1.03
4OXD chain B 0.57 0.63 – 0.56 0.65 0.86
4OXD chain C 0.66 0.64 0.56 – 0.56 0.64
4OXD chain D 0.69 0.76 0.65 0.56 – 0.61
4OXD chain E 0.80 1.03 0.86 0.64 0.61 –
Figure 6. A Comparison of the Ligand-Bound Active Sites Carboxy-
peptidases
(A) The active site of SpLdcB (white) with bound MurNAc—L-Ala-D-g-Gln—L-
Lys—(D-Asn) (turquoise carbons) is compared to that of VanXYg (blue) con-
taining a phosphinate transition state analog (pink carbons) of D-Ala—D-Ala
(PDB ID 4muq). The phosphinate in VanXYg coordinates the active site zinc in a
similar manner to that of the lysyl carboxylate in the MurNAc—L-Ala-D-
g-Gln—L-Lys—(D-Asn) bound to SpLdcB. The D-alanyl moiety of the phos-
phinate ligand in VanXYg, which occupies subsite S1
0, is matched by the
D-alanine (green carbons) in SpLdcB (white) and the D-Asn of the MurNAc—
L-Ala-D-g-Gln—L-Lys—(D-Asn) ligand. The zinc ions are shown as gray
spheres.
(B) The proposed positions of the two posthydrolysis ligands (orange carbons)
in the active site of SpLdcB (white). The D-alanine from the SpLdcB structure
occupies the S1
0 site of the protein, while the lysine side chain has been rotated
and modeled in an extended conformation. The altered conformation of the
lysine presents the Nz to the surface of the protein, in an ideal position to
accommodate peptide crosslinks. The zinc ions are shown as gray spheres.
(C) The active sites of SpLdcB and pancreatic carboxypeptidase A (PDB ID
1hdu [Cho et al., 2002]) are compared. In each structure, the Zn2+ ion is co-
ordinated by two histidines (His69 and His196 in carboxypeptidase A; His153
and His207 in SpLdcB) and an acidic amino acid (Glu72 in carboxypeptidase
A; Asp160 in SpLdcB). The reversed locations of Arg127 and Glu270 in
carboxypeptidase A relative to Arg120 and Glu204 in SpLdcB is matched by a
reversal of the path of the respective substrates through the active sites and
the likely retention of a common catalytic mechanism.
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therefore, distinct from the metalloprotease LdcB. It is inter-
esting that Csd6 can only hydrolyze D-Ala from monomeric
stem peptides, whereas LdcB is active against both monomeric
and crosslinked (tetra-tetra) stem peptides (Sycuro et al., 2013),
but the absence of structural similarity between these enzymes
precludes useful comparison.
While LdcB shares no structural homology with previously
studied LD-carboxypeptidases, DALI searches revealed a
strong similarity to members of the LAS superfamily. Of the
two consensus sequences that characterize the LAS family,
LdcB lacks the second His-rich motif, which is replaced spatially
by the invariant Glu204, which is oriented away from the zinc ion.
Given the residual activity of the E204A mutant (Figure 2A),
Glu204 probably plays an indirect role in catalysis. The zinc ion
probably plays a more direct role in catalysis, a hypothesis that
is supported by the absence of enzymatic activity in the pres-
ence of EDTA (Figures 2A and 2C). Further support for the role
of the metal ion, and the indirect role for the glutamate, comes
from studies of other zinc-dependent metalloproteases such
as pancreatic carboxypeptidase A, which is of historical impor-
tance given its role in the demonstration of Koshland’s induced
fit hypothesis (Christianson and Lipscomb, 1989; Koshland,
1958). Given the conformational changes seen on binding ligand
(Figure 7; Movie S1), LdcB appears to be another example of
induced fit. Though the two enzymes are structurally distinct,
the active sites of LdcB and pancreatic carboxypeptidase A
are, in essence, mirror images of one another. Both contain a
zinc ion coordinated by two histidines (His69 and His196 in
carboxypeptidase A; His153 and His207 in SpLdcB) and an
acidic amino acid (Glu72 in carboxypeptidase A; Asp160 in
SpLdcB). SpLdcB Arg120 and Glu204 straddle the nucleophilic
water, but their positions relative to their counterparts in pancre-
atic carboxypeptidase A (Arg127 and Glu270) are reversed (Fig-
ure 6C). Consequently, the path of the substrate through the
active site is also reversed. Given the retention of the metal
coordination and key adjacent amino acids in LdcB, it is entirely
plausible that the reactionmechanism of LdcB occurs in a similar
fashion to that of pancreatic carboxypeptidase A, utilizing the
metal ion to activate the nucleophilic water to attack the scissile
peptide bond. The enzymes would thus appear to have
converged on a common mechanism, despite sharing little
overall sequence and structural homology. Confirmation of the
catalytic mechanism utilized by this enzyme, and its precise
role in vivo, is the focus of current research activities in our
laboratories.
Figure 7. Conformational Changes in
SpLdcB on Ligand Binding
(A and B) Cartoon representations of (A) apo
SpLdcB and (B) SpLdcB with bound MurNAc-
Ala-D-g-Gln-Lys-(D-Asn) using the same color
scheme as in Figure 3. Key residues that move on
ligand binding are shown in stick representation.
EXPERIMENTAL PROCEDURES
Cloning
B. subtilis ldcB and S. pneumoniae ldcB were
amplified by PCR from B. subtilis 168 and
S. pneumoniae R6 genomic DNA, respectively, to generate fragments with
NdeI and XhoI restriction sites. Both fragments were digested with NdeI and
XhoI and ligated with NdeI/XhoI-digested pET28a. B. anthracis ldcB was
PCR amplified from B. anthracis str. Ames ancestor genomic DNA and cloned
into p15TV-LIC (Eschenfeldt et al., 2009) that codes for a N-terminal His6 tag,
followed by a tobacco etch virus (TEV) protease cleavage site. In all cases, the
recombinant constructs were designed to remove membrane-anchoring
amino acids to result in final clones encoding SpLdcB amino acids 56–238;
BsLdcB, 61–273; and BaLdcB, 55–243.
Strain Construction
S. pneumoniae R6DldcB was constructed by transforming strain R6 with
a PCR product covering the ldcB-deletion region from strain IU3880 (D39
Dcps2A0(cps2BCDETFG)H0DdacB <> Pc-kan-rpsL) amplified with primers
P136 and P137 (Barendt et al., 2011), followed by selection on tryptic soy broth
blood agar plates containing 250 mg/ml kanamycin. All strains were grown in
C + Y medium (Horne and Tomasz, 1993), containing kanamycin if required.
Competent bacteria were obtained as described elsewhere, with the addition
of competence-stimulating peptide (Vollmer and Tomasz, 2001).
B. subtilis strains were constructed by transformation of chromosomal DNA
(Anagnostopoulos and Spizizen, 1961; Young and Spizizen, 1961) from strains
bearing null mutations fordacA (MC01, trpC2DdacA cat) or yodJ (MC05, trpC2
DyodJ neo) into strain RD180 (trpC2 DalrA zeo), selecting for the appropriate
resistance markers (chloramphenicol or kanamycin at 5 mg/ml) in the presence
of 40 mg/ml D-alanine, yielding strains KS03 and KS02, respectively.
Growth Curves
B. subtilis strains RD180, KS02, and KS03 were grown overnight at 30!C in
Luria broth (LB) supplemented with 40 mg/ml D-Ala. The overnight cultures
were diluted 1:10 with LB supplemented with 40 mg/ml D-Ala and grown at
37!C for 2 hr. The cells were collected by centrifugation and resuspended in
D-Ala-free media at 37!C. This suspension was used to inoculate media
with various concentrations of D-Ala to an optical density 600 (OD600) of
0.05, and the subsequent growth of each culture at 37!C was monitored by
determining the optical density at 600 nm every 20 min for 3 hr. The growth
rate was determined during the exponential growth phase only.
Mutagenesis
A modified QuikChange protocol, incorporating ‘‘touchdown’’ (Don et al.,
1991), was used for site-directed mutagenesis. The annealing temperature
of the first 10 cycles was reduced by one degree per cycle, from 68!C to
58!C, before a further ten cycles were performed at a constant annealing
temperature of 58!C. The extension temperature was maintained at 72!C for
11min per cycle. Mutagenic primers (0.3 ml) were mixed with 50 ng of template
DNA, 0.5 mM dinucleotide triphosphates, and 2.5 U of Pfu DNA polymerase
in a total reaction volume of 20 ml. The template plasmid was digested using
DpnI.
Peptidoglycan Activity Assays
Cell wall and PG from S. pneumoniae and B. subtilis strains were isolated
by published procedures (Bui et al., 2012; Garcia-Bustos et al., 1988).
To test for LD-carboxypeptidase activity, PG from S. pneumoniae R6DldcB
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(1.6 mg/ml) or B. subtilis 168DldcB (3.1 mg/ml) was incubated in a total volume
of 160 ml of 20 mM sodium phosphate, pH 4.8, with 0.13 mg/ml SpLdcB and
0.31 mg/ml BsLdcB, respectively, for 16 hr at 37!C. If required, 0.6 mM Zn2+
or 10mMEDTAwas added, and control samples contained no added enzyme.
The PG was digested with 25 mg/ml of the muramidase cellosyl (a kind gift of
Hoechst AG) for 24 hr at 37!C. The samples were boiled for 10 min and centri-
fuged for 10 min at 15,000 3 g. The muropeptides present in the supernatant
were reduced with sodium borohydride and analyzed by high-pressure liquid
chromatography (HPLC) (Bui et al., 2012; Garcia-Bustos et al., 1988).
S. pneumoniae and B. subtilis muropeptide peaks were assigned based
on their published elution profile and retention times (Bui et al., 2012; Atrih
et al., 1999). Fractions containing the reduced muropeptides Tetra and
TetraTetra present in B. subtilis strain 168DldcB were collected and analyzed
by mass spectrometry (Bui et al., 2009). We determined a neutral mass of
940.4353 atomic mass units (amu) for Tetra (theoretical: 940.4237 amu) and
of 1862.8406 amu for TetraTetra (theoretical: 1862.8368 amu).
Thin-Layer Chromatography
Tetrapeptides Ala-D-Gln-L-Lys-D-Ala (Tetra-D; Activotec) or Ala-D-Gln-L-
Lys-L-Ala (Tetra-L; Activotec) at 20 mM were incubated with 700 uM of zinc-
loaded SpLdcB or SpLdcB-E153A for 2 hr at 37!C in a buffer of 10 mM
HEPES/NaOH, pH 8.0, 100mMNaCl in a reaction volume of 10 ml. One sample
of SpLdcB contained 50 mM EDTA. Ethanol (5 ml) was added to the reactions
before spotting on to silica gel thin-layer chromatography (TLC) aluminum foils
(Sigma). The TLCs were developed in a running buffer of butan-1-ol, acetic
acid, water in a 3:1:1 ratio for 40 min before staining with 0.1% ninhydrin solu-
tion in ethanol (Sigma). The TLC foils were dried and warmed with a domestic
hairdryer for visualizing the results.
Protein Overexpression and Purification
BsLdcB and SpLdcB were prepared in the same way. The proteins were over-
expressed in the methionine auxotrophic B834(DE3) strain of E. coli by growth
in LB media (or in minimal medium supplemented with selenomethionine for
selenomethionine-labeled protein) at 37!C up to an OD600 of 0.4 before induc-
tion with 1mM IPTG for 18 hr at 16!C. Cells were harvested by centrifugation at
3000 g for 25 min at 4!C and the pellet was resuspended in 40 ml buffer A
(50 mMHEPES.NaOH, pH 8.0, 300mMNaCl, 20mM imidazole) per liter of cul-
ture and lysed on ice for 3 min with a Sonopuls HD2070 (Bandelin) sonicator.
The cell lysate was clarified at 33000 g for 20 min and the supernatant loaded
onto a 5 ml Ni+-NTA column (GE Healthcare) pre-equilibrated with buffer A.
The column was washed with buffer A before elution of bound proteins with
buffer B (50 mM HEPES/NaOH, pH 8.0, 300 mM NaCl, 500 mM imidazole).
The fractions containing LdcB were pooled and the N-terminal hexahistidine
tag was removed by digestion with thrombin (Sigma-Aldrich) at 20!C for
16 hr at a ratio of 1 unit of enzyme per mg of LdcB. LdcB was concentrated
to a volume of 1 ml before loading onto a Superdex S75 HiLoad 16/60 (GE
Healthcare) gel filtration column pre-equilibrated in buffer C (10 mM HEPES/
NaOH, pH 8.0, 100 mM NaCl).
For BaLdcB, freshly transformed E. coli BL21-CodonPlus (DE3)-RIPL cells
were grown in 0.5 l of LB medium containing 100 mg/ml ampicillin. Cultures
were grown at 37!C to an OD600 of 0.8 and induced for 16 hr at 16
!C with
1 mM IPTG, and the cells were harvested by centrifugation and resuspended
in 20 ml of buffer A (50 mM HEPES, pH 7.5, 300 mM NaCl, 10% [v/v] glycerol)
supplemented with 10% (v/v) BugBuster 103 Protein Extraction Reagent
(Novagen), 25 U Benzonase (Sigma-Aldrich), and 5mM imidazole. Themixture
was stirred for 10 min at room temperature and centrifuged at 20,000 3 g for
45 min, and the supernatant was applied to a 1 ml HisTrap Fast Flow column
(GE Healthcare) equilibrated with buffer A containing 40 mM imidazole. The
protein was eluted with buffer A with a gradient of 40–500 mM imidazole
over 20 ml. Fractions containing the recombinant His-tagged proteins were
identified by SDS-PAGE; pooled; dialyzed overnight against 3 l of 50 mM
HEPES, pH 7.5, 300 mM NaCl, 5% (v/v) glycerol, 1 mM TCEP; and stored at
$80!C. The His6-tag was cleaved by TEV protease in 500 mM NaCl, 50 mM
Tris-HCl, pH 7.5, 1 mM TCEP, 1 mM EDTA, 20% glycerol.
Crystallization
BsLdcB and SpLdcB were concentrated to 15 mg/ml, and two molar equiv-
alents of zinc chloride were added. Crystallization conditions for BsLdcB
and SpLdcB were obtained by sitting drop vapor diffusion at 20!C. The
best SpLdcB crystals were obtained from a 0.1 M mixture of amino acids
(glycine, L-glutamate, and racemates of alanine, serine, and lysine), 0.1 M
Morpheus buffer system 2, pH 7.5, and 37.5% 2-Methyl-2,4-pentanediol
(MPD)/polyethylene glycol (PEG) 1000/PEG 3350 (Gorrec, 2009). A single
BsLdcB crystal grew from 0.1 M phosphate/citrate buffer, pH 4.2, 40%
PEG 300 over a period of #2 months. Crystals of SpLdcB with bound
MurNAc—L-Ala—D-g-Gln—L-Lys—(D-Asn) (InvivoGen) were obtained by
incubating the protein with the ligand at 2 mM final concentration for
30 min at room temperature prior to crystallization against a mother liquor
of 0.1 M ammonium chloride, 0.1 M HEPES/NaOH, pH 8.0, and 20% PEG
6000. Crystals of BaLdcB (zinc free) were grown at 23!C using hanging-
drop vapor diffusion by mixing 20 mg/ml protein with reservoir solution
containing 0.3 M sodium chloride, 0.1 M HEPES, pH 7.5. As soaking of
zinc chloride into BaLdcB apo-protein crystals did not provide sufficient oc-
cupancy of zinc into the active site, crystals of BaLdcB (zinc bound) were
grown at 23!C by hanging-drop vapor diffusion by mixing 20 mg/ml protein
and 5 mM zinc chloride prior to crystallization with 0.2 M ammonium acetate,
0.1 M sodium acetate, and 30% PEG 4000.
Data Collection and Processing
All crystals were cryoprotected with paratone-N before flash cooling in liquid
nitrogen prior to data collection at 100 K. Diffraction data for BsLdcB and
SpLdcB were on beamline IO2 of the Diamond Light Source. For selenome-
thionine-labeled SpLdcB, diffraction data were collected at a wavelength of
0.98 A˚ to permit phasing by selenomethionine-SAD (Se-SAD). Diffraction
data were integrated with XDS (Kabsch, 2010) and reduced with SCALA
(Evans, 2006). For BaLdcB, diffraction data were collected at on beamlines
21-ID-G at Life Sciences Collaborative Access Team, Advanced Photon
Source, at 0.97856 A˚ (selenomethionine peak; zinc free) and 1.27696 A˚ (Zn2+
peak; zinc bound). The BaLdcB diffraction data were integrated and reduced
with HKL-3000 (Minor et al., 2006).
Structure Solution
The structure of SpLdcB was solved using SHELX (Sheldrick, 2008) as imple-
mented in the HKL2MAP interface (Pape and Schneider, 2004). An initial model
was built by PHENIX.AUTOSOLVE (Adams et al., 2011). The completed
SpLdcB structure was used as the molecular replacement search model in
PHASER (McCoy et al., 2007) to solve BsLdcB and the SpLdcB-ligand com-
plex. The BaLdcB Zn2+-bound structure was solved by SAD phasing using
PHENIX.solve (Adams et al., 2011), which identified the positions of the two
bound Zn2+ ions. The occupancies of the zinc atoms were refined during
model refinement. The BaLdcB Zn2+-free structure was solved by molecular
replacement using the D,D-peptidase domain of the apo structure of VanXYG
(PDB ID 4f78) (Meziane-Cherif et al., 2014).
For all structures, manual building cycles in COOT (Emsley et al., 2010) were
interspersed with restrained refinement in PHENIX.REFINE (Afonine et al.,
2012). B factors were refined isotropically for all structures apart from BsLdcB,
which was refined anisotropically. Noncrystallographic symmetry refinement
was not used. Average B factor and geometric parameters were calculated
using PHENIX and verified with PHENIX.refine and the Research Collaboratory
for Structural Bioinformatics PDB Validation server. Data collection and final
model refinement statistics for all structures can be found in Table 1. The
graphics programs UCSF Chimera and PyMOL were used to generate all
molecular figures presented.
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